Effect of CaNa3DTPA on ischemia/reperfusion lesions induced in the hindlimb of rats;Ação do ácido trissódio-cálcio- dietilenotriaminopentaacético (CaNa3DTPA) nas lesões de isquemia-reperfusão em membro posterior de rato

Acta Cirurgica Brasileira

Volumn 17, Issue 5, 2002, Pages 332-341

  Francischetti, Ieda ^a   Maffei, Francisco Humberto De Abreu ^b   Bitu Moreno, Jose ^a,c   Fuhrmann Neto, Mário ^a   Coelho, Maria Paula Villela ^a   Kai, Fábio Hsu Tsu ^a   Sequeira, Julio Lopes ^b   Yoshida, Winston Bonetti ^b  

^a FACULDADE DE MEDICINA DE MARÍLIA   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c Faculdade de Medicina de Marília FAMEMA ^*  (Brazil)

Author keywords

Diethylenetriaminepentaacetic acid; Ischemia; Rats; Reperfusion; Skeletal muscle

Indexed keywords

EID: 36249019390     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/s0102-86502002000500009     Document Type: Article

References (35)

1. Menger MD, Messmer K. Die mikrozirkulation des skelettmuskels nach Ischaemie und reperfusion. Wiener Medizinische Wochenschrift 1993; 143:148-58.
2. Beyersdorf R, Matheis G, Krüger S, et al. Avoiding reperfusion injury after limb revascularization: Experimental observations and recommendations for clinical application. J Vasc Surg 1989; 9: 757-66.
3. Inauen W, Suzuki M, Granger DN. Mechanisms of cellular injury: potencial sources of oxygen free radicals in ischemia/ reperfusion. Microcir. Endoth. Lymphatics 1989; 5: 143-55.
4. Schlensak D, Doenst T, Bitu-Moreno J, Beyersdorf F. Controlled limb reperfusion with a simplified perfusion system. Thorac Cardiovasc Surg 2000; 48(5):274-8.
5. Martin J, Lutter G, Sarai K, Senn-Grossberger M, Takahashi N, Bitu-Moreno J, Haberstroh J, Beyersdorf F. Investigations on the new free radical scavenger polynitroxyl-albumin to prevent ischemia and reperfusion injury after orthotopic heart transplantation in the pig model. Eur J Cardiothorac Surg 2001; 19(3): 321-5.
6. Rouser G, Nelson GJ, Fleicher S et al. Lipid composition of animal cell membranes, organelles and organs. In: CHAPMAN, D. (ed) Biological membranes: physical fact and function. New York: Academic Press, 1968, v.1, p.5-69.
7. 3+ complex as the initiator. J Inorg Biochem.1997; 68 (4): 265-72.
8. Chevion MYJ, Har-Ei R, Berenshtein E et al. Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury. Proc. Natl. Acad. Sci 1993; 90: 1102-6.
9. Robinson E, Hedlund B. Role of iron in ischemia and reperfusion. Cire. Shock 1989; 27: 367.
10. Chiao JJC, Kirschner RE, Fantini GA. Iron delocalization occurs during ischemia and persists on reoxygenation of skeletal muscle. J Lab Clin Med 1994124:432-8.
11. Fantini GA, Kirschner RE, Chiao JJC. Reperfusion injury of postischemic skeletal muscle is attenuated by the 21-aminosteroids U-74389F and U-74500A independent of iron binding. Surgery 1996; 120 (5): 859-65.
12. Paller MS, Hedlund BE. Role of iron in postischemic renal injury in the rat. Kidney Int 1988; 34:474-80.
13. Krause GS, Joyce KM, Nayini NR et al. Cardiac arrest and resuscitation: brain iron delocalization during reperfusion. Ann Emerg Med 1985; 14: 1037-43.
14. Holt S, Gunderson M, Joyce K et al. Myocardial tissue iron delocalization and evidence for lipi peroxidation after two hours of ischemia. Ann Emerg Med. 1986; 15: 1155-9.
15. Gower JD, Healing G, Fuller BJ, et al. Iron redistribution and lipid peroxidation in the cold ischaemic kidney. Adv Exp Med Biol 1990, 264: 393-96.
16. Ambrosio G, Zweier JL, Jacobus WE et al. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation 1987; 76(4): 906-15.
17. Fantini GA, Yoshioka F. Deferoxamine prevents lipid peroxidation and attenuates reoxygenation injury in postischemic skeletal muscle. Am J Physiol 1993; 264: H1953-59.
18. Sardinha WE. Isquemia e reperflisão da musculatura esquelética em ratos. Inibição das lesões lipoperoxidativas mediadas por radicais livres pela deferoxamina. São Paulo, 1994. Tese, doutorado, Escola Paulista de Medicina.
19. Fahey JL, Rath CE, Princiotto JV et al. Evaluation of trisodium calcium diethylenetriaminepentaacetate in iron storage disease. J Lab Clin Med 1961; 57: 436-48.
20. Aisen P, Listowsky I. Iron transport and storage proteins. Annu Rev Biochem 1980; 49: 367-93.
21. Muller-Eberhard U, Erlandson ME, Glinn HE et al. Effect of trisodium calcium diethylenetriaminepenta acetate on bivalente cations in thalassemia major. Blood 1963; 22: 209-17.
22. Pippard MJ, Jackson MJ, Hoffman K et al. Iron chelation using subcutaneous infusion of diethylene triamine penta-acetic acid (DTPA). Scand J Haematol 1986; 36: 466-72.
23. Cinatl JJr, Hoffmann F, Cinatl J et al. In vitro inhibition of human cytomegalovirus replication by calcium trinatrium diethylenetriaminepentaacetic acid. Antiviral Res 1996; 31 (1-2): 23-34.
24. Brawn K, Fridovich I. Superoxide radical and superoxide dismutases: threat and defense. Acta Physiol. Scand. Suppl 1980; 492: 9-18.
25. Kazmierski WM, Wolberg G, Wilson JG et al. Iron chelates bind nitrix oxide and decrease mortality in an experimental model of septic shock. Proc Natl Acad Sci 1996; 93: 9138-41.
26. Scholz M, Cinatl J, Markus BH. Immunomodulation and anticytomegalovirus activity of antioxidant metal chelators. Transplant Proc 1997; 29 (1-2): 1272-3.
27. Pryor WA. The formation of free radicals and the consequences of their reactions in vivo. Photochemistry & Photobiology 1978; 28 (4-5): 787-801.
28. Lindsay F, Walker PM, Mickle DAG, et al. Measurement of hydroxy-conjugated dienes after ischemia-reperfusion in canine skeletal muscle. Am. J. Physiol 1988; 254: H578- 83.
29. Rall TW. Hypnotics and sedatives; Ethanol. In: GILMAN, A.G., RALL, T.W., NIES, A.S., et al. - The fharmacological basis of therapeutics. New York, McMillan Publishing Co., 1990, cap. 17, p. 345-82.
30. Hamazaki S, Okada S, Li J-L, et al. Oxygen reduction and lipid peroxidation by iron chelates with special reference to ferric nitrilotriacetate. Archives of Biochemistry and Biophysics 1989; 272 (1): 10-7.
31. Baker MS, Gebicki JM. The effect of pH on the conversion of superoxide to hydroxyl free radicals. Archives of Biochemistry & Biophysics 1984; 254 (1): 258-64.
32. Watanabe BI, Limm W, Suehiro A, et al. Failure of deferoxamine to reduce myocardial infarct size in a primate model of ischemia-reperfusion injury. Journal of Surgical Research 1993; 55: 537-42.
33. McCord JM, Day ED Jr. Superoxide-dependent production of hidroxyl radicals catalyzed by the iron-EDTA complex. FEBS Lett 1978; 86: 139.
34. Borg DC, Schaich KM. Pro-oxidant action of desferrioxamine: Fenton like production of hydroxyl radicals by reduced ferrioxamine. J Free Radical Biol Med 1986; 2: 237.
35. Pearson PJ, Evora PR, Seccombe JF. et al. Hypomagnesemia inhibits nitric oxide release from coronary endothelium: protective role of magnesium infusion after cardiac operations. Annals of Thoracic Surgery 1998; 65 (4): 967-72.